Underpinning the Future of Healthcare with High Performance Computing and Artificial Intelligence.

The need for a faster, more fluid research environment is driving the adoption of advanced computing technologies

Time-to-market, accelerated research programmes and quicker decision making are key criteria for pharmaceutical companies with a pipeline of novel products in development and the wider life science ecosystem. The adoption of AI and machine learning in healthcare, enhanced 3D genomics using graphic processing units (GPUs) and high-performance computing (HPC) is increasingly speeding up the drug discovery timeframe. But, how can we make this technology more accessible, what best practice can we learn from application – large and small today and how will it influence and drive forward the future of digitised healthcare?


PAUL TUNNAH | Founder and Chief Content Officer, | pharmaphorum and Healthware Group


KEVIN COX | Chair | Biorelate
LEE MYALL | Chief Executive Officer | Kao Data
NICK PAPPAS | Strategic Partnerships, Life Sciences | The Hartree Centre | STFC | UKRI
ANDREW PIERCE | VP of Translational Biology | Crescendo Biologics
CRAIG RHODES | Industry Business Lead Healthcare and Life Science | NVIDIA